Table 6.
Mean MSC/ MLL
| VISDA | HC | KMC | SOM (MSC) | SOM (MCLL) | SFNM fitting |
Ground truth |
|
|---|---|---|---|---|---|---|---|
| Synthetic data | 5.68e+0(4) /−6.19e+0 |
9.52e+0 (6) |
5.52e+0 (1) |
5.52e+0 (1) |
5.52e+0 (1) |
5.68e+0(4) /−6.19e+0 |
5.78e+0 |
| SRBCTs | 5.46e+1(4) /−5.99e−1 |
7.41e+1 (5) |
4.76e+1 (1) |
4.76e+1 (1) |
5.12e+1 (3) |
1.09e+2(6) /−8.33e+1 |
5.22e+1 |
| Multiclass cancer | 1.71e+5(5) /−4.21e+1 |
1.65e+5 (4) |
1.56e+5 (1) |
1.56e+5 (1) |
1.58e+5 (3) |
5.89e+5(6) /−3.88e+1 |
1.60e+5 |
| Lung cancer | 5.02e+5(4) /−7.15e+1 |
5.49e+5 (5) |
4.32e+5 (1) |
4.32e+5 (1) |
4.33e+5 (3) |
1.53e+6(6) /−6.70e+1 |
5.40e+5 |
| UM cancer | 9.07e+7(5) /−6.53e+1 |
8.99e+7 (4) |
5.42e+7 (1) |
5.42e+7 (1) |
5.68e+7 (3) |
9.25e+7(6) /−6.52e+1 |
8.75e+7 |
| Ovarian cancer | 5.10e+7(4) /−1.84e+2 |
5.87e+7 (5) |
4.72e+7 (1) |
4.72e+7 (1) |
4.73e+7 (3) |
8.74e+7(6) /−1.64e+2 |
5.70e+7 |
| MMM-cancer 1 | 4.58e+6(5) /−8.98e+1 |
3.95e+6 (4) |
3.01e+6 (1) |
3.01e+6 (1) |
3.32e+6 (3) |
6.26e+6(6) /−8.90e+1 |
4.72e+6 |
| MMM-cancer 2 | 2.42e+8(5) /−1.53e+2 |
1.41e+8 (4) |
1.18e+8 (1) |
1.18e+8 (1) |
1.29e+8 (3) |
3.16e+8(6) /−1.50e+2 |
2.66e+8 |
| Average rank of MSC | 4.5 | 4.63 | 1 | 1 | 2.75 | 5.75 | N/A |
Mean MSC is shown with performance rank in parentheses. Best MSC obtained on each dataset is indicated by bold font. Mean MLL is shown only for VISDA and SFNM fitting. Better MLL of VISDA and SFNM fitting method is also indicated by bold font. “Ground truth” indicates the MSC calculated based on the ground truth biological categories.